US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist
  • 13.090
  • +0.320+2.51%
Close Nov 27 16:00 ET
  • 13.090
  • 0.0000.00%
Post 20:01 ET
762.20MMarket Cap-4609P/E (TTM)

About Cullinan Therapeutics Company

Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Company Profile

SymbolCGEM
Company NameCullinan Therapeutics
Listing DateJan 8, 2021
Issue Price21.00
Founded2016
CEOMr. Nadim Ahmed
MarketNASDAQ
Employees85
Fiscal Year Ends12-31
AddressOne Main Street,Suite 1350
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-410-4650
Websitehttp://cullinantherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Nadim Ahmed
  • Director, President and Chief Executive Officer
  • 4.01M
  • Dr. Jeffrey Alan Jones, M.D.
  • Chief Medical Officer
  • 2.42M
  • Dr. Corinne Savill, PhD
  • Chief Business Officer
  • --
  • Mary Kay Fenton
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Jacquelyn L. Sumer
  • Chief Legal Officer, Chief Compliance Officer and Secretary
  • --
  • Dr. Jennifer Michaelson, PhD
  • Chief Scientific Officer
  • --
  • Anthony Rosenberg
  • Chairman of the Board
  • 284.84K
  • David D. Meek
  • Director
  • --
  • Dr. David P. Ryan, M.D.
  • Independent Director
  • 43.75K
  • Dr. Anne-Marie Martin, PhD
  • Independent Director
  • 164.45K
  • Stephen W. Webster
  • Independent Director
  • 232.24K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data